Searched for
GLENMARK GENERICS LTD INDIA
For investors looking beyond the short-term horizon: 5 mid-cap stocks from different sectors with upside potential up to 28%All is once again quiet on the US-Iran war front, and some kind of dialogue to resolve the issues between the two seems to be still underwa...- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Glenmark working on proprietary product rolloutThe company plans to build a global manufacturing footprint, increase presence in complex generics, launching of specialty business in the ...
- IFC plans to invest $ 75 million in Glenmark Pharmaceuticals"The company aims to raise up to $ 200 million through market issuance of quasi-equity instruments to finance the project, of which IFC pro...
- Glenmark gets USFDA nod for post-menopause osteoporosis drugThe approval for sale of Norethindrone Acetate and Ethinyl Estradiol tablets was given to Glenmark Generics Inc USA, a subsidiary of Glenma...
- USFDA gives nod for Riluzole tablets to Sun Pharma, GlenmarkSun Pharma and Glenmark have got approval from US health regulator to sell generic versions of nervous system disorder treatment drug Riluz...
- Glenmark recalls select lot of oral contraceptive in USGlenmark Pharmaceuticals today said it has issued a voluntary nationwide recall in the US for seven lots of its oral contraceptive Norgesti...
- Sebi approves IPO of Glenmark’s generics armThe Securities and Exchange Board of India (Sebi) has approved the initial public offering (IPO) of Glenmark Generics, the wholly-owned sub...
- Glenmark: Bright future in the UK and beyondWith its global headquarters in Mumbai, pharmaceutical group Glenmark does business in over 60 countries around the world.
- CRISIL assigns IPO grade 4/5 to Glenmark GenericsCRISIL has assigned IPO Grade 4/5 to the proposed IPO of Glenmark Generics Ltd, which indicates that the fundamentals of the IPO are above ...
- Glenmark Generics files for IPOGlenmark Generics, the generics arm of Glenmark Pharmaceuticals, on Wednesday filed the draft prospectus with Sebi to raise Rs 550-600 cror...
- Glenmark Pharma launches blood pressure tablets in UKGlenmark Pharmaceuticals on Thursday said its European subsidiary has launched in the UK its first product - Perindopril tablets.
- Glenmark to reorganise biz into two unitsThe company’s generic business will come under a wholly owned subsidiary, Glenmark Generics, while innovative research initiatives and bran...
- Glenmark to reorganise biz into specialty, genericsThe new generic entity, called Glenmark Generics, will be a subsidiary of the company and will be listed on the bourses by April-June 2008-...
- Trileptal copy seen boosting Glenmark's US sales by $20 mnIndia’s Glenmark Pharmaceuticals is likely to record sales of about $20 million in the United States for its generic version of Novartis’ e...
Load More
